The PaceNew therapies / indications available since the last 12 months 
Velphoro
BY: Olive TseDec 15, 2020

Velphoro

(sucroferric oxyhydroxide)
Fresenius Kabi

 

Composition:

Available in chewable tablet with each contains 500 mg iron as sucroferric oxyhydroxide also known as a mixture of polynuclear iron(III)-oxyhydroxide, sucrose, and starches

 

Indication:

For the control of serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis

 

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.
The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.

 

You May Be Interested In
LETYBO
BY: Winnie TangApr 19, 2024
TEZSPIRE®
BY: Eura SoJun 20, 2024
Trodelvy
BY: Winnie TangDec 18, 2023
AQUIPTA®
BY: Dr. Mohsin RoshanOct 22, 2024